Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur® Adults

Vaccine

Volumn 27, Issue 6, 2009, Pages 853-856

  Plentz, Annelie ^a   Jilg, Wolfgang ^a   Schwarz, Tino F ^b   Kuhr, Hans B ^c   Zent, Olaf ^d  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Stiftung Juliusspital   (Germany)

^c Practice   (Germany)

^d Novartis Vaccine   (Germany)

Author keywords

Booster; Immunogenicity; Tick borne encephalitis; Vaccine

Indexed keywords

ANTIBODY; INACTIVATED VACCINE; TICK BORNE ENCEPHALITIS VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; TICK BORNE ENCEPHALITIS; VACCINATION;

ADULT; ANTIBODIES, VIRAL; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; TIME FACTORS; VIRAL VACCINES; YOUNG ADULT;

EID: 58249118007     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.082     Document Type: Article

References (26)

1. Dumpis U., Crook D., and Oksi J. Tick-borne encephalitis. Clin Infect Dis 28 4 (1999) 882-890
2. Lesnicar G., Poljak M., Seme K., and Lesnicar J. Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000. Pediatr Infect Dis J 22 7 (2003) 612-617
3. UK Department of Health (DoH). Immunisation against infectious disease-the Green Book; 2006. http://www.dh.gov.uk/en/Policyandguidance/Healthandsocialcaretopics/Greenbook/DH_4097254 (accessed 8 May 2008).
4. World Health Organization (WHO). Tick-borne encephalitis; 2007. http://www.who.int/vaccine_research/diseases/vector/en/index2.html (accessed 8 May 2008).
5. Gritsun T.S., Nuttall P.A., and Gould E.A. Tick-borne flaviviruses. Adv Virus Res 61 (2003) 317-371
6. Kunz C. TBE vaccination and the Austrian experience. Vaccine 21 Suppl 1 (2003) S50-S55
7. Süss J., Klaus C., Diller R., Schrader C., Wohanka N., and Abel U. TBE incidence versus virus prevalence and increased prevalence of the TBE virus in Ixodes ricinus removed from humans. Int J Med Microbiol 296 Suppl 40 (2006) S63-S68
8. International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). 3rd ISW-TBE Newsletter; February 2007. http://www.isw-tbe.info/upload/medialibrary/ISW-TBE_Newsletter_February_2007.pdf (accessed 8 May 2008).
9. Barrett P.N., Plotkin S.A., and Ehrlich H.J. Tick-borne encephalitis virus vaccines. In: Plotkin S.A., Orenstein W.A., and Offit P.A. (Eds). Vaccines. 5th ed. (2008), Philadelphia, Saunders 841-856
10. Standing Vaccination Commission of the Robert Koch Institut (STIKO). Epidemiological Bulletin 17; 2006 http://www.rki.de/cln_049/nn_197444/DE/Content/Infekt/EpidBull/Archiv/2006/17__06.html?__nnn=true (accessed 8 May 2008).
11. Bundesamt für Gesundheit (BAG). Empfehlungen zur Impfung gegen Zeckenenzephalitis; 2006. http://www.bag.admin.ch/themen/medizin/00682/00684/01069/index.html?lang=de (accessed 8 May 2008).
12. Impfplan 2007 Österreich. http://www.zecken.at/upload/medialibrary/Impfplan_200775907.pdf (accessed 8 May 2008).
13. Robert Koch Institut (RKI). Zecken auf demVormarsch: Borreliose und FSME im Gepäck; 2007 http://www.rki.de/cln_048/nn_466802/DE/Content/InfAZ/B/Borreliose/Fsme__Borreliose,templateId=raw,property=publicationFile.pdf/Fsme_Borreliose.pdf (accessed 8 May 8 2008).
14. ® Erwachsene. 2008.
15. Zent O., Jilg W., Plentz A., Schwarz T.F., Frühwein N., Kuhr H.B., et al. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults. Vaccine 21 32 (2003) 4655-4660
16. Zent O., Beran J., Jilg W., Mach T., and Banzhoff A. Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults. Vaccine 21 7-8 (2003) 738-741
17. Zent O., Schwarz T.F., Plentz A., Banzhoff A., and Jilg W. TBE booster immunization in adults-first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Int J Med Microbiol 293 Suppl 37 (2004) S134-S138
18. Zent O., Plentz A., Schwarz T.F., Frühwein N., Kuhr H.B., Broeker M., et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?. Vaccine 23 (2004) 312-315
19. Zent O., Hennig R., Banzhoff A., and Bröker M. Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers. J Travel Med 12 2 (2005) 85-93
20. Klockmann U., Bock H.L., Kwasny H., Praus M., Cihlová V., Tomková E., et al. Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization. Vaccine 9 1 (1991) 42-46
21. Zent O., Banzhoff A., Hilbert A.K., Meriste S., Słuzewski W., and Wittermann Ch. Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer. Vaccine 21 25-26 (2003) 3584-3592
22. Schöndorf I., Beran J., Cizkova D., Lesna V., Banzhoff A., and Zent O. Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule. Vaccine 25 8 (2007) 1470-1475
23. Rendi-Wagner P., Zent O., Jilg W., Plentz A., Beran J., and Kollaritsch H. Persistence of antibodies after vaccination against tick-borne encephalitis. Int J Med Microbiol 296 Suppl 40 (2006) S202-S207
24. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B., and Kollaritsch H. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up. Vaccine 25 27 (2007) 5097-5101
25. Schöndorf I., Schönfeld C., Nicolay U., Zent O., and Banzhoff A. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule. Int J Med Microbiol 296 Suppl 40 (2006) S208-S212
26. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B., and Kollaritsch H. Seroprotection 4 years following booster vaccination against tick-borne encephalitis. Int J Med Microbiol 298 Suppl 1 (2008) S305-S308